October 31, 2022
Via: The Wall Street JournalRival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor […]
July 9, 2024
June 25, 2024